RESUMEN

Carbon monoxide has recently emerged to promote tissue regeneration, enhance the innate immune system, and have anti-inflammatory and antibacterial properties. While the first generation Ru(II) carbonyl prodrugs (CORM-2 and CORM-3) displayed several beneficial biological effects, a search in the literature shows that little work has been done to address the drawbacks of CORM-2/-3, exploring other CO triggered methods for the next generation Ru(CO)2II based compounds and examining their valuable biological impact. We present a summary of most work related to Ru(II) carbon monoxide-releasing molecules, protein bioconjugation, and antibacterial and anti-inflammatory properties.

Asunto(s)

Compuestos Organometálicos , Rutenio , Antibacterianos/química , Antiinflamatorios/farmacología , Monóxido de Carbono/metabolismo , Monóxido de Carbono/farmacología , Compuestos Organometálicos/farmacología , Rutenio/química , Rutenio/farmacología